Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dimitrios, Krikelis"'
Autor:
Dimitrios T. Trafalis, Athanasios Tampakis, Anastasia Pazaiti, Constantinos Alifieris, Michalis Kontos, Dimitrios Krikelis, Ekaterini Christina Tampaki
Publikováno v:
Clinical Drug Investigation. 38:639-648
In the era of personalized therapy, targeted treatment in specific patient populations is mandated. We evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent against vascular endoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccafbe7110088fdb0ab7971faca90c8c
https://doi.org/10.1007/s40261-018-0655-z
https://doi.org/10.1007/s40261-018-0655-z
Autor:
Ioannis Boukovinas, Dimitrios Krikelis, P. Makrantonakis, Georgios Koumakis, Konstantinos N. Syrigos, Hara Kousoulakou, Paraskevas Kosmidis, Argyro Markouri, M Geitona, Epaminondas Samantas, V. Georgoulias
Publikováno v:
Pharmacoeconomics: Open Access.
Objective: To investigate the resource use and costs associated with the management of metastatic anaplastic lymphoma kinase inhibitors (ALK+) NSCLC in Greece. Methods: The resource use was based on the outcomes of a Delphi panel with seven oncologis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84640212d23bfbf3644b43cabd543506
https://doi.org/10.4172/2472-1042.1000109
https://doi.org/10.4172/2472-1042.1000109
Autor:
Ian Judson, Dimitrios Krikelis
Publikováno v:
Expert Review of Anticancer Therapy. 10:249-260
Soft tissue sarcomas are a diverse group of rare tumors that comprise 1% of all cancers. Few randomized trials of chemotherapy have been performed but there is a clear role for agents such as doxorubicin and ifosfamide in the palliation of advanced d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1b6e0e456871ab86524fb268217729
https://doi.org/10.1586/era.09.176
https://doi.org/10.1586/era.09.176
Autor:
Dimitrios, Krikelis, Vassiliki, Kotoula, Mattheos, Bobos, Elena, Fountzilas, Konstantinos, Markou, Ilias, Karasmanis, Nikolaos, Angouridakis, Konstantinos, Vlachtsis, Konstantine T, Kalogeras, Angelos, Nikolaou, George, Fountzilas
Publikováno v:
Anticancer research. 34(11)
There exist substantial evidence that laryngeal cancer represents a unique entity among squamous head and neck carcinomas.Tumors from 289 patients with squamous cell laryngeal cancer were assessed for protein (immunohistochemistry) and mRNA (qRT-PCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3acf07dac18fbf386eca021979ab0bce
https://pubmed.ncbi.nlm.nih.gov/25368251
https://pubmed.ncbi.nlm.nih.gov/25368251
Autor:
Dimitrios, Krikelis, Evangelia, Skoura, Vassiliki, Kotoula, Phivi, Rondogianni, Nikoletta, Pianou, Alexandros, Samartzis, Ioannis, Xanthakis, George, Fountzilas, Ioannis E, Datseris
Publikováno v:
Anticancer research. 34(5)
Although Kirsten rat sarcoma (KRAS) gene mutational testing is essential for the optimal design of therapeutic strategies for colorectal cancer, it is not always feasible or reliable. In this retrospective study, we examined whether (18)F-Fluorodeoxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc2a8f0e69afb9ece4ad3343956ed5e9
https://pubmed.ncbi.nlm.nih.gov/24778079
https://pubmed.ncbi.nlm.nih.gov/24778079
Autor:
Konstantinos, Kamposioras, Athina, Konstantara, Vassiliki, Kotoula, Sotiris, Lakis, George, Kouvatseas, Evangelos, Akriviadis, Eleni, Vrettou, Dimitrios, Dionysopoulos, Dimitrios, Krikelis, Kyriaki, Papadopoulou, Elpida, Charalambous, Sofia, Chrisafi, Christos, Konstantaras, George, Fountzilas
Publikováno v:
Anticancer research. 33(10)
The wingless-type MMTV integration site family of proteins (WNT) pathway is highly involved in colorectal cancer development. The aim of this study was to explore the prognostic significance and clinicopatological correlations of this pathway in a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b8058dcf18e274f5f16851c032861e8
https://pubmed.ncbi.nlm.nih.gov/24123033
https://pubmed.ncbi.nlm.nih.gov/24123033
Autor:
Vasilios Karavasilis, Despina Televantou, Ippokratis Korantzis, Dimitrios Pectasides, Anastasia G Eleftheraki, George Fountzilas, Dimitrios Krikelis, Vassiliki Kotoula, Christos Christodoulou, Paris Kosmidis, Stefanos Dimoudis, Konstantinos N. Syrigos, Triantafillia Koletsa
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 342 (2012)
BMC Cancer
BMC Cancer
Background BRCA1 (B), ERCC1 (E), RRM1 (R) and TYMS (T) mRNA expression has been extensively studied with respect to NSCLC patient outcome upon various chemotherapy agents. However, these markers have not been introduced into clinical practice yet. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f518575ae932ef40f36a7ada3645740d
http://www.biomedcentral.com/1471-2407/12/342
http://www.biomedcentral.com/1471-2407/12/342
Autor:
Dimitrios T. Trafalis, Nikolaos M. Sitaras, Athanassios E. Athanassiou, Constantinos Alifieris, Dimitrios Krikelis, Nikolaos Tzogkas, George P. Stathopoulos
Publikováno v:
International journal of clinical pharmacology and therapeutics. 50(7)
BACKGROUND Malignant pleural mesothelioma (MPM) is an aggressive disease with poor or modest responses to chemotherapy and dismal prognosis. In most of the cases the scope of the treatment is only palliative. In the current study, the combination of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4214f330f87da7eedd50837be6c1d44
https://pubmed.ncbi.nlm.nih.gov/22578202
https://pubmed.ncbi.nlm.nih.gov/22578202
Autor:
Aikaterini, Stoyianni, Anna, Goussia, George, Pentheroudakis, Vassiliki, Siozopoulou, Elli, Ioachim, Dimitrios, Krikelis, Vassilios, Golfinopoulos, Andres, Cervantes, Mattheos, Bobos, Theodoros, Fotsis, Sofia, Bellou, Georgios, Fountzilas, Vassiliki, Malamou-Mitsi, Nicholas, Pavlidis
Publikováno v:
Anticancer research. 32(4)
The epithelial to mesenchymal transition (EMT) has been associated with metastatic dissemination and poor outcome in several solid tumour types. Our aim was to study its incidence and its prognostic significance in cancer of unknown primary (CUP).One
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::673ce84cfedbc9521b215cc149ad45ca
https://pubmed.ncbi.nlm.nih.gov/22493359
https://pubmed.ncbi.nlm.nih.gov/22493359
Autor:
Angelos K, Koutras, Dimitrios, Krikelis, Natassa, Alexandrou, Ioannis, Starakis, Haralabos P, Kalofonos
Publikováno v:
Anticancer research. 27(6C)
Sunitinib (SU011248; Sutent) is a new small molecule that inhibits members of the split-kinase domain family of receptor tyrosine kinases (RTKs), with established antitumor activity in renal cancer. In the current report, we describe a patient with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c1658f8c9044fca063064d29eb679f2
https://pubmed.ncbi.nlm.nih.gov/18214028
https://pubmed.ncbi.nlm.nih.gov/18214028